# Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms

> **NCT03876444** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Suvasini Sharma** · enrollment: 128 (estimated)

## Conditions studied

- Infantile Spasm

## Interventions

- **DRUG:** Intravenous Methylprednisolone
- **DRUG:** Oral Pednisolone

## Key facts

- **NCT ID:** NCT03876444
- **Lead sponsor:** Suvasini Sharma
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-10-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876444, "Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03876444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*